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T-cell receptor (TCR) polyclonal matureT cells are surprisingly resistant to oncogenic trans-
formation after retroviral insertion of T-cell oncogenes. In a mouse model, it has been
shown that mature T-cell lymphoma/leukemia (MTCLL) is not induced upon transplanta-
tion of mature, TCR polyclonal wild-type (WT) T cells, transduced with gammaretroviral
vectors encoding potent T-cell oncogenes, into RAG1-deficient recipients. However, fur-
ther studies demonstrated that quasi-monoclonal T cells treated with the same protocol
readily induced MTCLL in the recipient mice. It has been hypothesized that in the TCR
polyclonal situation, outgrowth of preleukemic cells and subsequent conversion to overt
malignancy is suppressed through regulation of clonal abundances on a per-clone basis due
to interactions between TCRs and self-peptide-MHC-complexes (spMHCs), while these
mechanisms fail in the quasi-monoclonal situation. To quantitatively study this hypothesis,
we applied a mathematical modeling approach. In particular, we developed a novel ordinary
differential equation model of T-cell homeostasis, in which T-cell fate depends on spMHC-
TCR-interaction-triggered stimulatory signals from antigen-presenting cells (APCs). Based
on our mathematical modeling approach, we identified parameter configurations of our
model, which consistently explain the observed phenomena. Our results suggest that the
preleukemic cells are less competent than healthy competitor cells in acquiring survival
stimuli from APCs, but that proliferation of these preleukemic cells is less dependent on
survival stimuli from APCs. These predictions now call for experimental validation.
Keywords:T-cell homeostasis,T-cell niche, gene therapy, matureT-cell lymphoma, MTCL
1. INTRODUCTION
Mature T cells are an essential component of the adaptive immune
system. They carry the so-called T-cell receptor (TCR) on their
surface. This receptor enables them to recognize peptides that are
presented to them via major histocompatibility complex (MHC)
molecules on antigen-presenting cells (APCs). A vast number of
different TCRs is expressed in T cells in healthy individuals, esti-
mated to be in the order of 106 in mice (1) and 107 in humans (2).
An individual T cell expresses a single TCR variant, and passes this
variant on to its daughter cells. The set of all T cells expressing the
same TCR is called a T-cell clone (or simply referred to as clone).
The enormous TCR diversity is created during T-cell maturation
in the thymus through genomic rearrangement of the TCR gene
locus (3). A series of selection processes ensures that mature T cells
can bind with low to moderate affinity to self-peptide-MHC com-
plexes (spMHCs) on APCs (4–6). After maturation, T cells enter
the peripheral T-cell pool.
The peripheral T-cell pool is remarkably stable in terms of cell
numbers and clonal diversity throughout the lifetime of mice and
humans. In order to explain this stability, concepts have emerged
that are based on competition between T cells for limiting trophic
resources needed for survival and proliferation (7). The limit-
ing trophic resources can be divided in public and TCR-specific
resources (8). In principle, public trophic resources are equally
accessible to all T cells, and include stimulatory cytokines (e.g.
interleukin 7), nutrients, costimulatory molecules, or physical
space. In contrast, access to TCR-specific resources depends on the
particular TCR that is expressed on a T cell. TCR-specific resources
are represented mainly by stimulatory interactions with APCs due
to binding of the TCR to spMHCs (9–11).
Different spMHCs may vary substantially in their suitability
to mediate a stimulatory interaction for particular T-cell clones.
Consequently, a T-cell niche concept has been proposed, in which
different spMHCs represent distinct T-cell niches (12). The niches
provide vital resources that different T-cell clones compete for. A
particular clone may not receive resources from all niches equally
well. This concept implies that the TCR diversity is stabilized by
the diversity of the available spMHCs (13).
When the regulation of cellular proliferation in the T-cell sys-
tem is corrupted, mature T-cell lymphoma/leukemia (MTCLL)
formation may occur. However, oncogenesis is comparatively rare
in mature T cells. For example, the incidence of B-cell lym-
phoid neoplasms is substantially higher than the incidence of
T-cell/natural killer cell lymphoid neoplasms, as shown in a study
from the United States (26.13/105/year vs. 1.79/105/year (14)).
Furthermore, several studies from the field of retroviral gene
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therapy confirm the relative resistance of mature T cells to onco-
genesis. Despite long follow-up times, retroviral vector-induced
oncogenesis has never been observed in clinical gene therapy tri-
als involving gene-modified mature T cells (15–17). In contrast,
genotoxicity was observed in several studies involving retrovi-
ral gene transfer into hematopoietic stem and progenitor cells
(HSPCs) (18, 19).
Motivated by these observations, we here focus on the analysis
of oncogenesis control in mature T-cell populations.
In order to explicitly investigate the relative resistance of mature
T cells to malignant transformation in a gene therapeutic context,
HSPCS, and mature T cells were exposed to an identical transfor-
mation assay in a defined experimental setting (20). In this assay,
HSPCs and mature T cells were isolated from wild-type mice and
were each transduced independently with high copy numbers of
gammaretroviral vectors encoding potent T-cell oncogenes. Sub-
sequently, the cells were transplanted into immunoincompetent
RAG1-deficient mice. HSPC-transplanted animals consistently
developed MTCLL. In contrast, MTCLL has not been observed
in any of the recipients that were transplanted with mature T cells.
This finding corroborated the relative resistance of mature T cells
to malignant transformation.
In a subsequent study, the impact of TCR diversity on T-cell
resistance to malignant transformation has been further assessed
(21). In this study, T-cell populations were isolated from OT1- or
P14-mice, i.e. mice expressing a transgenic TCR. T-cell popula-
tions from these mouse models are quasi-monoclonal, i.e. they
express predominantly one specific TCR. By applying a simi-
lar, yet refined, transformation assay as in the previous study
MTCLL readily developed in the recipient RAG1-deficient mice
(see Figure 1). Moreover, addition of untransduced TCR poly-
clonal T cells to quasi-monoclonal, transduced cell populations
prevented malignancy development, demonstrating that TCR
polyclonality plays a pivotal role in malignancy control in mature
T cells.
Building on these observations, we hypothesize that in the
TCR polyclonal situation, prohomeostatic signals, due to inter-
actions between TCRs and spMHCs, suppress the outgrowth of
preleukemic T cells (i.e. in this context, T cells that have been
transformed by retroviral insertion of an oncogene), while these
mechanisms fail in the TCR quasi-monoclonal situation, and vig-
orous cell expansion occurs. In this paper, we aim to quantitatively
assess the implications of this hypothesis using a mathematical
modeling approach. Specifically,we develop a mathematical model
of a niche-dependent mature T-cell regulation [similar to previ-
ous published models, e.g. Ref. (22)], which will be applied to
model the physiological situation and MTCLL formation. Using
this model of T-cell homeostasis, we present an in silico simula-
tion scenario that is suited to mimic the experimental procedures
performed by Newrzela et al. (20, 21). In an extensive parameter
screen, we evaluate if, and under which parameter constellations
the experimental observations can be explained.
2. MATERIALS AND METHODS
2.1. MODEL DESCRIPTION
The two major entities in our model are T-cell species (also called
simply species) and T-cell niches (also called simply niches). With
the term species, we refer to a set of T cells that is homogeneous
in terms of our model parameters. In the physiological situa-
tion, a T-cell clone can be represented as a particular species.
However, in order to model the aforementioned experimental sit-
uation (20, 21), we will represent each T-cell clone by two species,
namely a species representing healthy cells within a clone and
a preleukemic species representing cells that potentially give rise
to MTCLL.
Our model is constructed to describe the temporal dynamics
of species abundances, i.e. the number of cells belonging to a par-
ticular T-cell species at any point of time. The number of species
in the system is denoted by the symbol m. The species abundances
at time t are represented by the vector c(t )= (ct(t )) with i= 1,
2, . . ., m. The initial species abundances c(0) are defined by an
m-dimensional vector denoted c0 =
(
c0i
)
.
In the model, T-cell species compete for resources needed
for survival and proliferation that are supplied by T-cell niches.
The number of niches in the system is denoted by the symbol
n. It is assumed that the niches supply resources at constant
rates, represented by the n-dimensional vector p= (pj), where
j = 1, 2, . . ., n.
The competition for niche resources between species is defined
by the m× n matrix A= [aij], called niche affinity matrix, in which
aij is a measure of the capability of species i to acquire resources
from niche j.
At any time point t, species receive resources from niches
according to instantaneous rates. These rates, which are termed
resource acquisition rates, are stored in an m× n matrix
R(t )= [rij(t )]. rij(t ) denotes the rate at which the i-th species
receives resources from the j-th niche at time t, and is the affinity-
and abundance-weighted proportion of the total rate pj at which
Polyclonal 
mature T cells
LeukemiaTransduction with 
T-cell oncogenes
(NPM/ALK, TrkA)
Rag1 -/-
Rag1 -/- No leukemia
Quasi-monoclonal
mature T cells
FIGURE 1 | Experimental strategy as described in Newrzela et al. (21). TCR quasi-monoclonal T-cell populations transduced with potent T-cell oncogenes
developed mature T-cell lymphoma/leukemia in RAG1-deficient recipient mice, while TCR polyclonal T-cell populations that have been subjected to the same
transformation assay did not.
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niche j provides resources. Thus, rij(t ) is calculated as follows:
rij(t ) =

aij ci (t )
m∑
k=1
akj ck (t )
pj if
m∑
k=1
akj ck(t ) > 0
0 otherwise
The sum of the resource acquisition rates over all niches yields
the net resource acquisition rate for a particular species.
Different T-cell species may differ in the amount of resources
needed to sustain an individual cell. Therefore, we introduce the
m-dimensional vector v= (vi), which we term resource utilization
efficiency. This parameter determines for each species, how many
T cells can be sustained by one resource unit per unit of time. The
product of the resource acquisition rates and the resource utiliza-
tion efficiencies yields the time-dependent carrying capacities of
the individual species, stored in the vector k(t )= (ki(t )):
ki(t ) = vi
n∑
j=1
rij(t )
The carrying capacities indicate how many cells of a given
species can be sustained by the system, given the current resource
distribution among the species. The carrying capacities may
change dynamically in time, as the species abundances vary. The
relation between the actual size of a species and the carrying
capacity determines whether the species abundance decreases or
increases. Due to lack of biological data determining a particular
growth model for T-cell clones, we chose a rather general logistic
growth dynamics, where τ denotes the minimum cell cycle time:
dci(t )
dt
=
{
ci (t )
τ
(1− ci (t )ki (t ) ) if ki(t ) > 0
0 if ki(t ) = 0
We require c0i , aij, pj, and vi to be greater than or equal to zero,
and τ to be greater than zero.
2.2. PARAMETER CHOICE
In its general form, the model presented in the previous subsec-
tion has nm+ 2m+ n+ 1 scalar parameters. In the following, we
sketch our numerical approach and reparameterize the model in
order to reduce the effective number of parameters.
In our approach, the number of TCR-defined clones is denoted
by q. Each clone is represented by two species (thus m= 2q). With-
out loss of generality, species 1 to q represent the presumably
healthy cells within the q clones (referred to as healthy species)
and species q+ 1 to 2q represent the cells that potentially give
rise to leukemia/lymphoma (referred to as preleukemic species).
The specific case of the monoclonal situation is represented by
setting all but the first healthy and the first preleukemic initial
species abundances to zero (ci= 0 except c1> 0, cq + 1> 0). We
assume that each species may in principle receive a stimulus from
each niche due to unspecific affinity. The magnitude of the unspe-
cific affinity is denoted u(h) for the healthy species and u(p) for
the preleukemic species. In addition, we assume that each species
has a preferred niche, to which it has an additional affinity [spe-
cific affinity, denoted s(h) for the healthy species and s(p) for the
preleukemic species]. Biologically, the specific affinity could be
interpreted as affinity to cognate self-peptide, and the unspecific
affinity as affinity to the MHC itself.
The scalar parameters describing the specific and the unspecific
affinities are used to define the niche affinity matrix A. Formally,
we construct the matrices A(h) =
[
a(h)ij
]
describing the niche
affinities of the healthy species and A(p) =
[
a
(p)
ij
]
describing the
niche affinities of the preleukemic species as follows,
a(h)ij =
{
s(h) + u(h) if i = j
u(h) if i 6= j
a
(p)
ij =
{
s(p) + u(p) if i = j
u(p) if i 6= j
i ∈ {1, 2, ..., q}, j ∈ {1, 2, ..., n}
and use these matrices in order to construct the actual niche
affinity matrix A by vertical concatenation of A(h) and A(p):
A =
[
A(h)
A(p)
]
Furthermore, we introduce the symbols v(h) and v(p) to
describe the resource utilization efficiencies of the healthy and
preleukemic species, respectively. v(h) and v(p) are used to con-
struct the actual resource utilization efficiencies (superscript T
denoting the transpose of a vector):
v = (v(h), . . . , v(h)︸ ︷︷ ︸
q times
, v(p), . . . , v(p)︸ ︷︷ ︸
q times
)
T
Note that no interspecies heterogeneity with respect to the
magnitudes of the specific and unspecific affinities of the healthy
species (s(h), u(h)) and their resource utilization efficiency v(h)
is considered. The same applies to the preleukemic species, with
parameters s(p), u(p), and v(p).
In order to make numerical simulations feasible, while still pre-
serving the niche-based regulation, we are using a system with
100 niches (n= 100) and 100 clones (q= 100), i.e. 200 species
(m= 200) for the numerical simulations.
As mentioned above, the real number of T-cell clones in mice
is estimated in the order of 106, while the total number of T cells
in a mouse is estimated to be in the order of 108 (23). Assuming
that in the physiological situation the number of niches in mice
equals the number of T-cell clones, a niche nourishes 100 cells
on average. Therefore, we consider the niche sizes pj= 100 for all
j = 1, . . ., 100. The minimum cell cycle time τ is set to 8 h as a
rough estimate of vigorous T-cell proliferation (24). Since an ini-
tial exploratory screen did not reveal a qualitative effect of changes
in niche size p and the minimum cell cycle time τ on the model
behavior, we keep p and τ fixed to the above described values.
Additionally, and without loss of generality, we can fix one of
the four niche affinity parameters s(h), s(p), u(h), and u(p) as the dis-
tribution of resources depends on relative affinities only. We chose
to fix the unspecific affinity of the healthy cells u(h)= 1/n= 0.01
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(n being the number of niches) as our reference. The specific affin-
ity of the healthy species s(h) is set to 1 [except for the results
shown in Figure 6, in which we are also considering the values
s(h)= 0.2 and s(h)= 5]. Furthermore, we set the resource utiliza-
tion efficiency of the healthy cells v(h) to 1, thus interpreting the
corresponding value of the preleukemic cells v(p) as a relative
measure compared to the healthy situation.
Hence, at this point the scalar parameters s(p) (specific affin-
ity of the preleukemic species), u(p) (unspecific affinity of the
preleukemic species), v(p) (resource utilization efficiency of the
preleukemic species), and the vector-valued initial condition c0
are not yet fixed. How they are varied in the parameter screen is
described in the following subsection.
2.3. SIMULATION PROCEDURE
2.3.1. Physiological situation
In order to study the behavior of the system, we in silico transplant
500 cells into an empty system. TCR diversities q= 1 and q= 100
are considered. In the TCR polyclonal situation, the initial species
abundances c0 are obtained by distributing the 500 cells according
to a uniform distribution over the healthy species. s(h) is set to 1.
The parameters s(p), u(p), and v(p), which describe the properties
of the preleukemic species, do not influence the model behavior
here, since no preleukemic cells are transplanted into the system.
All other model parameters are fixed to the above described val-
ues. We let the system evolve for 400 time-steps. To demonstrate
the system response to perturbations, we simulate a significant cell
loss by removing 99% of the cells at time t = 200. The simulation
results are presented in subsection 1.
2.3.2. Oncogenic situation
In order to systematically evaluate the effect of the parameters
describing the properties of the preleukemic cells [i.e. their specific
affinity s(p), their unspecific affinity u(p), their resource utilization
efficiency v(p)] and the initial abundances c0, we perform an exten-
sive parameter screen. s(p), u(p), and v(p) are varied in multiples
of their healthy counterparts, ranging from ∼1/40 to ∼40. The
relative distances between two neighboring values is 20%, so that
41 different fold-changes are considered per parameter.
The fraction of transplanted cells that have been transformed
into preleukemic cells is currently not known for the used
experimental protocol. Therefore, we consider three scenarios,
denoted P1, P10, and P100, which consider 1, 10, and 100 initial
preleukemic cells, respectively. All three scenarios are evaluated
for each combination of the specific affinity of the preleukemic
species s(p), their unspecific affinity u(p), and their resource uti-
lization efficiency v(p). All cases are initiated by 500 cells that are
in silico-transplanted into an empty system.
This corresponds to 5 cells per clone in the polyclonal situation
on average, in accordance with the experimental situation (5× 106
transplanted cells, TCR diversity estimated in the order of 106).
In scenario P1, one T cell (0.2%) is assigned to the preleukemic
cell compartment, in scenario P10, 10 T cells (2%), belonging to
10 different species in the TCR polyclonal situation, are assigned
to the preleukemic cell compartment, and in scenario P100, 100
T cells (20%), belonging to 100 different species in the polyclonal
situation. In all three scenarios, the remaining cells are distributed
randomly according to a uniform probability distribution over
the healthy species in the polyclonal situation. In addition to the
polyclonal settings we construct a corresponding monoclonal sit-
uation, in which the fraction of 0.2% (P1), 2% (P10), or 20%
(P100) preleukemic cells is assigned to only a single clone.
The number of parameter sets evaluated in each of the three
scenarios is 413 (since 41 different fold-changes are considered for
s(p), u(p), and v(p)). Hence, in total 3× 413≈ 2× 105 parame-
ter sets are evaluated for both the polyclonal and the monoclonal
situation.
As we are not primarily interested in transient phenomena but
in the long-term behavior of the system, our aim is the identifica-
tion and characterization of stable steady states, namely whether
the preleukemic cells are able to dominate the system or not. There-
fore, simulations are run until the relative change of all species
abundances between two successive time steps are below 10−6.
For this situation we assume that the system is sufficiently close to
a steady state. If this criterion is not fulfilled after 108 simulation
steps, the current simulation is stopped, and the stability of the
system will be assessed manually.
For each individual parameter set, we evaluate if the corre-
sponding simulations for the mono- and polyclonal situation are
consistent with the experimental phenomena, i.e. if we observe a
stable and considerably enlarged population of preleukemic cells
in the monoclonal situation, and control of the preleukemic cells in
the polyclonal situation (i.e. the contribution of the preleukemic
cell population remains below a certain threshold). The specific
criteria used for the classification are listed in Table 1. If a parame-
ter set fulfills all criteria, we consider it consistent with the observed
phenomena as described in (20, 21).
The simulation results of the parameter screen are presented in
subsection 2.
3. RESULTS
3.1. PHYSIOLOGICAL SITUATION
First, we investigate the behavior of the described system in the
absence of preleukemic cells. As can be seen in Figure 2, the sys-
tem quickly converges to a steady state, both in the mono- and the
Table 1 | Criteria used for classification.
Total cell count Contribution of
preleukemic cells
TCR monoclonal
situation
At least 300% of
physiological cell count
At least 80% of total cell
count
TCR polyclonal
situation
At most 120% of
physiological cell count
At most 50% of total cell
count
A particular tested parameter set is classified as consistent with the experimental
phenomena, if the total cell count and the contribution of the preleukemic cells
fulfill the criteria specified in the table, i.e. a leukemia-like situation in theTCR mon-
oclonal situation, and a state of non-dominance of the preleukemic species in the
TCR polyclonal situation. The total cell count at the steady state is compared to
the physiological cell count, which is established based on the simulations shown
in subsection 1.The contribution of the preleukemic cells is the ratio between the
number of preleukemic cells and the total cell count at the steady state.
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FIGURE 2 | Simulation results of physiological situation. The left panel
documents the dynamic system behavior in the monoclonal situation. In the
right panel, the individual green lines represent the abundance of different
clones. The system quickly converges to a steady state. The total cell count in
the steady state of the physiological situation is indicated by the horizontal
dashed green line at 104. The horizontal red line at 3×104 represents the total
cell count that is required as a minimum in order to qualify a situation as
premalignant. At t =200, 99% of the cells are removed from the system.
Both in the mono- and the polyclonal situation the system quickly
reestablishes the previous steady state.
polyclonal situation. In the polyclonal situation, all clones have
an abundance of 100 cells at the steady state due to the para-
meter symmetry among the healthy species (i.e. all species have
the same specific affinity s(h)= 1 to their preferred niche, and the
same unspecific affinity u(h)= 1/n to all niches). The total cell
count at the steady state amounts to v(h) ·
n∑
j=1
pj = 104 both in the
monoclonal and the polyclonal situation. After a perturbation, e.g.
due to cell kill, the system quickly reestablishes its previous state,
unless individual species are completely eliminated within the cell
kill simulation.
The steady state with equal-sized clones is reached regardless
of the initial abundances of the healthy cells, given that the abun-
dances of all healthy species are >0 (data not shown). Transient
changes of the niche sizes or transient addition of niches (e.g. to
model infections) can entail the transient expansion of one more
species/clones (data not shown).
3.2. ONCOGENIC SITUATION
For the oncogenic situation, we evaluate whether a certain pro-
portion of preleukemic cells (represented by the three scenarios
P1, P10, and P100) can develop into a (pre)leukemic situation
in the monoclonal case, while being controlled by healthy com-
petitor cells in the polyclonal case. The evaluation is carried out
based on prespecified formal criteria (see Table 1). In all tested
parameter settings, the steady state (i.e. convergence) criterion is
reached both in the mono- and the polyclonal situation. Figure 3
shows representative simulation results to provide some intuition
about the spectrum of possible simulation outcomes for the three
scenarios P1, P10, and P100.
Out of the ≈2× 105 tested parameter configurations, 1050
parameter sets are consistent with the experimental phenomena
according to the defined criteria (c.f. Table 1). Further, it should be
emphasized that the consistent parameter sets are identifiable as a
confined region in the parameter space in all three scenarios (see
Figure 4) and that the regions in scenarios P1, P10, and P100 over-
lap considerably. In all three scenarios, we identify a region that is
characterized by lowered specific and unspecific affinities as well
as an increased resources utilization of preleukemic compared to
normal T cells. Technically, this refers to triangular prisms in the
u
(p)
low s
(p)
low v
(p)
high octant of the parameter cube (Figure 4). In scenario
P1, the region of consistent parameter sets additionally extends
to the u
(p)
low s
(p)
highv
(p)
high octant. Our results indicate that the overall
systems behavior displays only a minor dependency on the initial
number of preleukemic cells with respect to the phenomena in
focus.
Assessing the set of consistent parameter constellations in more
detail, we find that the resource utilization efficiency parameter for
the preleukemic species v(p) had to be chosen at least three-fold
higher than the resource utilization efficiency for healthy cells, in
order to be consistent with the experimental observations. This is
more clearly seen in Figure 5, which further characterizes the para-
meter sets that are consistent with the predefined criteria. The fact
that a three-fold increase of v(p) is required, directly reflects crite-
rion from Table 1, stating that the cell counts have to be increased
at least three-fold in the monoclonal situation.
Concerning the niche affinities of the preleukemic cells, a clear
pattern can be observed, likewise apparent in Figure 5. In sce-
narios P10 and P100, the specific affinity of the preleukemic cells
s(p) is decreased (i.e. s(p)< s(h)) in all consistent parameter sets.
In scenario P1, however, the specific affinity can be considerably
increased without rendering a tested parameter set inconsistent.
This is due to the fact that in scenario P1, only a single cell is
preleukemic initially. Therefore, the fitness of the preleukemic cell
www.frontiersin.org November 2013 | Volume 4 | Article 380 | 5
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gerdes et al. Mathematical modeling of T-cell oncogenesis
Simulation time
A
b
u
n
d
a
n
c
e
10
0
10
2
10
4
10
6
Physiological level
Preleukemic level
Scenario P1:
1 preleukemic cell at t=0
T
C
R
 M
o
n
o
c
lo
n
a
l
0 200 400 600 800 1000
Scenario P10:
10 preleukemic cells at t=0
T
C
R
 M
o
n
o
c
lo
n
a
l
Scenario P100:
100 preleukemic cells at t = 0
T
C
R
 M
o
n
o
c
lo
n
a
l
0 200 400 600 800 1000
T
C
R
 P
o
ly
c
lo
n
a
l
T
C
R
 P
o
ly
c
lo
n
a
l
0 200 400 600 800 1000
10
0
10
2
10
4
10
6
T
C
R
 P
o
ly
c
lo
n
a
l
Healthy cells
Preleukemic cells
Total cell count
s
(p)
=0.58, u
(p)
=0.043, v
(p)
=38 s
(p)
=1.72, u
(p)
=0.0025, v
(p)
=0.33 s
(p)
=0.026, u
(p)
=0.093, v
(p)
=15
FIGURE 3 | Simulation results of three representative parameter sets.
For each scenario, we show the simulation results of one possible
parameter set. The parameter set picked for scenario P1 is not consistent
with the experimental observations as specified inTable 1. The preleukemic
cells expand more than threefold both in the mono- and polyclonal situation.
The parameter set chosen for P10 is also not consistent with the specified
criteria. Using this parameter set, the preleukemic cells are less fit than the
healthy cells, and die out both in the mono- and the polyclonal situation. The
parameter set chosen for scenario P100 is consistent with the specified
criteria.
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FIGURE 4 | 3D scatter plot of consistent parameter sets. Each
tested parameter set can be represented by a point in one of the
three presented cubes, the coordinates representing the fold-changes
of s(p ), t (p ), and v (p ) in comparison with their healthy counterparts s(h),
u (h), and v (h). In the center of each cube, the parameters s(p ), u (p ), and
v (p ) are equal to their counterparts describing the healthy cells. Only
the parameter sets that are consistent with the experimental
observations (criteria inTable 1) are plotted. Transparency is used in
order to give an impression of the shape of the consistent parameter
region.
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FIGURE 5 | Histograms of consistent parameter values. These histograms
show the distribution of the specific affinity of the preleukemic species s(p),
their unspecific affinity u (p), and their resource utilization efficiency v (p) of the
consistent parameter sets. s(p) is decreased in all consistent parameter sets
of scenario P10 and P100, while it is indifferent in scenario P1. u (p) is
decreased and v (p) is increased in all consistent parameter sets.
pool (i.e. proliferative potential) increases only marginally in the
polyclonal situation if the specific affinity of the preleukemic cells
s(p) is increased. In contrast, in scenario P10 and P100, the fit-
ness of the preleukemic cell population in the polyclonal situation
responds more sensitively to an increase of the specific affinity
of the preleukemic cells due the greater TCR diversity within the
preleukemic cell population. Because of that, the preleukemic cells
cannot be controlled by healthy competitor cells in the polyclonal
situation, even if the specific affinity is only mildly increased,
rendering such parameter sets inconsistent.
The unspecific affinity of the preleukemic cells is decreased
in all consistent parameter sets (i.e. u(p)< u(h)). This reduc-
tion generates a disadvantage of preleukemic species for accessing
resources from non-preferred niches, thus prohibiting a dominat-
ing expansion. Nonetheless, the preleukemic species must have at
least some residual unspecific affinity in order to generate results
that are consistent with the experimental situation. Specifically,
the residual unspecific affinity allows them to access resources
from the unprotected niches in the monoclonal situation. With-
out this ability, these cells cannot outgrow the healthy species in
this situation. When comparing the decrease of the specific and the
unspecific affinity of the preleukemic cells (u(p)), it stands out that
in scenarios P10 and P100, the specific affinity of the preleukemic
cells (s(p)) is decreased to a greater degree than the unspecific affin-
ity (u(p)) in all consistent parameter sets. In contrast, the decrease
of the specific affinity of preleukemic cells (s(p)) is greater than
their decrease in unspecific affinity (u(p)) in only ≈30% of the
consistent parameter sets in scenario P1. Hence, if only a single
preleukemic cell is present initially, the ability to receive a stimu-
lus due to interaction with cognate self-peptide may be preserved
or even increased, while in the situation of many initially present
preleukemic cells the simulation results are not consistent with the
experimental phenomena.
Furthermore, our simulations demonstrate that there is a rather
strict functional relation between the unspecific affinity of the
preleukemic cells (u(p)) and their resource utilization efficiency
(v(p)) for all consistent parameters (see Figure 6). In other words,
a certain acquired growth advantage, which is mediated by an
increase in resource utilization (v(p)), requires a corresponding
decrease in the unspecific affinity (u(p)) to guarantee consistency.
Interestingly, the stringency of this relation depends crucially on
the specific affinity of the healthy cells (s(h)). To illustrate this
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efficiencies v (t ). The relation between these quantities is relatively strict. All
points are contained between two parallel lines. In this plot, we show
additional simulation results, in which also the specific affinity of the healthy
cells s(h) is varied.
relationship, we tested the system behavior also for s(h)= 0.2 and
s(h)= 5 in addition to the value s(h)= 1 used so far. Although vary-
ing values of s(h) do not qualitatively change the system behavior,
the size of the consistent parameter region, i.e. the number of con-
sistent parameter sets, is affected considerably by the particular
choice of s(h): it is larger for s(h)= 5 and smaller for s(h)= 0.2.
This can be seen in Figure 6, which illustrates the relationship for
different values of s(h).
Interpreting the specific affinity as affinity to cognate self-
peptide, and the unspecific affinity as affinity to the MHC itself,
the ratio of the specific and the unspecific affinity of the healthy
cells (i.e. s(h)/u(h)) determines how strict the regulation exerted
by the self-peptide defined niches is. If the ratio is large, the niche
regulation is strict, i.e. T cells can hardly access resources from
niches other than their preferred niche. If the ratio is small, T cells
can acquire more resources from niches other than their preferred
niche. Our simulation results indicate that the stronger the niche
regulation (i.e. a larger s(h)), the larger is the consistent parameter
region, and hence the more robust are the modeling results and
the biological behavior of the system.
4. DISCUSSION
Oncogenesis in mature T cells and especially the resistance to
malignant transformation of these cells even in potent oncogenic
transformation assays have raised substantial interest in these cell
populations. In a series of experiments, it has been shown that
the resistance of mature T cells depends on the diversity of the
TCR repertoire. Specifically, MTCLLs could readily be induced
in T-cell populations that are quasi-monoclonal with respect to
their TCR, while oncogenesis occurred only in rare cases in the
TCR polyclonal situation, despite identical experimental condi-
tions (20, 21). This observation led to the hypothesis that in the
polyclonal situation, regulation based on competition for survival
stimuli mediated by interaction between TCRs and spMHCs on
APCs can prevent the expansion of preleukemic cells. Further-
more, the hypothesis implies that this regulation fails in the
quasi-monoclonal situation,and the preleukemic cells expand,and
eventually give rise to overt malignancy.
We have developed and applied a mathematical model of T-cell
homeostasis to qualitatively and quantitatively challenge this con-
cept. In the model, mature T cells compete for resources that are
provided by T-cell niches. Biologically, the resources correspond to
survival stimuli from APCs due to interactions between spMHCs
and the TCR. The different T-cell niches are defined by the dif-
ferent spMHCs found on APCs. Due to differential affinities of
different TCRs to spMHCs, T cells may differ in their capability to
acquire resources from a particular niche.
Within this modeling framework we systematically evaluated
the effect of the model parameters. For each specific parameter set,
we tested if it is consistent with the observed phenomena according
to the criteria in Table 1.
In order to achieve consistency with the criteria, the niche affini-
ties of the preleukemic cells had to be decreased (i.e. s(p)< s(h)
and u(p)< u(h), while their resource utilization efficiency had to
be increased (i.e. v(p)> v(h)). Biologically, this suggests that the
preleukemic cells are less dependent on niche resources (decreased
affinities). In particular, our results predict a stronger decrease of
the specific affinity of the preleukemic cells (s(p)) compared to the
unspecific affinity (u(p)).
This implies that in the presence of healthy competitor cells
with preference for the same niche, the preleukemic cells can be
outcompeted. In the polyclonal situation this preventive effect
acts on almost all niches, thus keeping the preleukemic cells at
a minimum or even making them disappear.
In contrast, in the monoclonal situation the vast majority of
niches is unguarded by healthy cells, and their resources can,
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therefore, be accessed by the preleukemic cells due to their albeit
small, but non-zero unspecific affinity (u(p)). In this situation, the
decrease in the affinities can be compensated by the increase of
the resource utilization efficiency of the preleukemic cells (v(p)).
Metaphorically speaking, the polyclonal healthy competitor cells
protect the niche resources against the aggressive preleukemic cells
in the polyclonal situation. If the polyclonal guards in the form
of healthy competitor cells are not present, the preleukemic cells
are able to claim all or most of the niche resources and promote
MTCLL occurrence.
Transferring our findings back into a mechanistic context,
we speculate that the decreased model affinities correspond to
a down-regulation of TCR-mediated regulations and/or impair-
ment of intracellular TCR signaling, i.e. a reduced T-cell avidity
(25). A more efficient utilization of these signals (i.e. an increase in
v(p)) can be interpreted as a partial independence of preleukemic
cells from environment-mediated growth signals, or as failure
to respond adequately to inhibitory signals. On an intracellu-
lar level this independence might be achieved by a constitutive
up-regulation of growth-promoting pathways.
In order to describe the T-cell system, and in particular the
experiments performed by Newrzela et al. in mathematical terms
we made a number of simplifying assumptions. It is a long-
standing notion that oncogenesis often develops in a multi-step
process (26). Also, in the context of gene therapy, it has been
described that oncogenesis may occur directly (single hit induc-
tion), or may require additional lesions (cooperating hit induction)
(27, 28). In our simulation scenario, however, we consider the
effect of a first but fully effective hit only, i.e. we assume a virtually
instantaneous effect of the oncogene affecting all preleukemic cells
after transduction. In principle, it would be possible to incorporate
cooperating hits into our model that are subsequently acquired
after transplantation. We refrained from doing so, since only pre-
liminary experimental data on tumor evolution in the context of
the phenomena in focus are available to date.
Similarly, we did not account for heterogeneity concerning the
effect of the oncogene, i.e. all cells belonging to the preleukemic
cell compartment are assigned the same functional alteration in
the model. Also, it is not clear, if our model adequately describes
the emergence of preleukemic cells on an individual clone level.
Hopefully, such individual clone data will be available in the future,
so that we will be able to validate our model in this regard.
In order to make numeric simulations feasible, we considered
a system with only 100 niches and 100 T-cell clones in the poly-
clonal situation. This is several orders of magnitude below the
estimated TCR diversity in mice, and the estimated number of
self-peptides that can be presented per allele [∼105 Ref. (13)].
However, there is significant cross-reactivity (i.e. presence of TCRs
that may recognize more than one spMHC) in the T-cell system
(29), so that the number of functionally relevant, distinct niches
may be considerably lower. Being well aware of these simplifica-
tions, we consider the proposed system dimensions as sufficient in
order to capture the general niche-based structure of the mature
T-cell system.
Although we successfully demonstrated that suppression of
preleukemic T cells due to TCR-related regulation in the polyclonal
situation can consistently explain the experimental observations,
we are aware that alternative explanations could also account for
the observed phenomena. Definitive proof or disproof of the niche
regulation hypothesis will require further experimental work.
Therefore, our conceptual understanding of T-cell oncogen-
esis will be challenged in further experiments. Specifically, we
suggest to compare the phenotype of the leukemic/preleukemic
cells with the phenotype of the healthy competitors regarding,
e.g. their gene expression profile, their activation of relevant sig-
naling pathways and their functional properties (30). This will
allow assessing whether our assertions about the properties of the
preleukemic cells (i.e. down-regulation of the TCR/TCR signaling
and up-regulation of growth-promoting pathways) are correct.
Our modeling results predict that there is a minimum clonal
diversity that is needed in order to control preleukemic T cells
as produced in the previous experiments. Further transplantation
experiments are planned to determine the minimum TCR diversity
in clonality titration experiments.
All simulations presented in this publication start with a
hypocellular condition. However, additional simulations (data not
shown) demonstrated that the model results are generally not
dependent on the initial abundance of a species, as long as it is
present at all. Therefore, our results apply also to leukemogen-
esis with physiological onset conditions as it occurs in clinical
settings. The situation in which the malignancy develops from a
single mutated cell (as can be expected for the majority of patients)
corresponds to the presented scenario P1.
Central to this work is our assumption that the abundances
of individual TCR-defined clones are regulated on a per-clone
basis due to interactions with spMHCs. However, many aspects
of the insinuated regulation are elusive to date. This is at least
partially due to the fact that in the in vivo situation, accurate and
precise time-dependent quantification of individual TCR-defined
clones with abundances in the physiological range is technolog-
ically challenging, if not impossible, to date. Nonetheless, such
a concept is intellectually appealing, and seems plausible on a
mechanistic level. We hypothesize that this regulation is (at least
in part) responsible for the relatively low incidence of mature
T-cell malignancies relative to mature B-cell malignancies. This
hypothesis would imply less effective control mechanisms in the
mature B-cell system, which might be caused by the fact that clonal
homeostasis in the mature B-cell system is presumably more com-
plex than in the T-cell system, due to affinity maturation of the
B-cell receptor, and ongoing influx of newly generated mature
B-cell clones from the bone marrow. These complicating factors
may undermine the effectiveness of the leukemia control mecha-
nisms proposed for the mature T-cell system in the mature B-cell
system.
So far in this publication, the unspecific affinities u(h) and u(p)
are interpreted in terms of TCR affinity for the MHC molecule
itself. However, these unspecific affinities could also represent the
reliance of T-cell survival on survival cytokines, e.g. interleukin 7.
Further studies could aim to disentangle these two potential com-
ponents of the unspecific affinity. To do so, the use of mouse
models with a restricted MHC repertoire might be useful.
As exemplified in this paper, mathematical modeling
approaches allow for the quantitative assessment of functional
principles of T-cell interactions, their integration into a consistent
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conceptual framework and the derivation of testable hypotheses.
Our results add a new puzzle piece to the complex picture of
mature T-cell homeostasis. The hypothesis that regulation based
on TCR-defined clonal membership suppresses MTCLL emer-
gence may serve as a novel starting point to delve deeper into
the mechanisms governing the homeostatic behavior of mature
T cells.
Our modeling results prompt further experimental research to
clarify the nature of the differential transformability of mature
T cells. Moreover, our work demonstrates the general ability of
theoretical approaches to formalize and conceptually validate the
results of experimental research and promotes the idea of an
iterative, interdisciplinary approach to research in immunology.
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